Albemarle (ALB) official guidance

Albemarle (ALB) official earnings guidance and management outlook. Each figure management stated is shown with its revisions and the source quote.

See the full Filings Intelligence suite
ALBALBEMARLE CORPQ1 FY2027 · ends 2027-03-31
1 metric1 new
earnings call · 2026-08-07 04:01:23 UTC
2026-08-07 04:01:23 UTCreaches full run ratenew
To ensure adequate contingency for our downstream operations, we've assumed CGP3 reaches full run rate in the first quarter of 2027.
ALB · transcript · Q2 FY2026
2026-08-07 04:00:00 UTCOpen source
ALBALBEMARLE CORPFY2026 · ends 2026-12-31
2 metrics1 new1 maintained
earnings call · 2026-08-07 04:01:23 UTC
2026-08-07 04:01:23 UTC$100M – $150Mmaintained
We are also on track to reach the high end of our $100 to 150 million full-year target for cost and productivity improvements.
ALB · transcript · Q2 FY2026
2026-08-07 04:00:00 UTCOpen source
2026-05-08 04:01:18 UTC$100M – $150Mmaintained
We are on track to deliver our full year cost and productivity improvements of $100 million-$150 million.
ALB · transcript · Q1 FY2026
2026-05-08 04:00:00 UTCOpen source
2026-02-13 05:02:02 UTC$100M – $150Mnew
We are also targeting additional cost and productivity improvements of $100 million-$150 million and stable capital spending in 2026.
ALB · transcript · Q4 FY2025
2026-02-13 05:00:00 UTCOpen source
2026-08-07 04:01:23 UTC$87.5Mnew
On a full year basis, we still expect cash flow to be impacted by $87.5 million of deferred revenue related to our 2025 customer prepayment, which benefits EBITDA but does not contribute cash, and approximately $100 million of spend related to idling Kemerton Train 1.
ALB · transcript · Q2 FY2026
2026-08-07 04:00:00 UTCOpen source
ALBALBEMARLE CORPQ3 FY2026 · ends 2026-09-30
1 metric1 new
earnings call · 2026-08-07 04:01:23 UTC
2026-08-07 04:01:23 UTCdecrease sequentiallynew
For the third quarter, net sales and adjusted EBITDA are expected to decrease sequentially due to lower sales volumes and assuming that pricing is lower sequentially for the quarter as it stands today.
ALB · transcript · Q2 FY2026
2026-08-07 04:00:00 UTCOpen source
ALBALBEMARLE CORPFY2026 · ends 2026-12-31
1 metric1 maintained
earnings call · 2026-08-07 04:01:23 UTC
2026-08-07 04:01:23 UTC$275M – $325Mmaintained
As a result, we are increasing our full-year outlook ranges, raising net sales to $1.4 to 1.6 billion and adjusted EBITDA to $275 to 325 million.
ALB · transcript · Q2 FY2026
2026-08-07 04:00:00 UTCOpen source
2026-08-05 20:24:05 UTC$275M – $325Mraised +20.0%
| Specialties adjusted EBITDA | $275 - $325 million |
ALB · EX-99.1 · Q2 FY2026
2026-08-05 20:22:29 UTCOpen source
2026-05-08 04:01:18 UTC$225M – $275Mmaintained
We are raising our guidance for net sales to $1.3 billion-$1.5 billion and for adjusted EBITDA to $225 million-$275 million.
ALB · transcript · Q1 FY2026
2026-05-08 04:00:00 UTCOpen source
2026-05-06 20:21:16 UTC$225M – $275Mraised +25.0%
| Specialties adjusted EBITDA | $225 - $275 million |
ALB · EX-99.1 · Q1 FY2026
2026-05-06 20:19:37 UTCOpen source
2026-02-13 05:02:02 UTC$170M – $230Mmaintained
Looking ahead to 2026, we are introducing full year outlook considerations for the specialties business, including net sales of $1.2-$1.4 billion, adjusted EBITDA of $170-$230 million, and EBITDA margins in the mid-teens.
ALB · transcript · Q4 FY2025
2026-02-13 05:00:00 UTCOpen source
2026-02-11 21:25:10 UTC$170M – $230Mnew
| Specialties adjusted EBITDA | $170 - $230 million |
ALB · EX-99.1 · Q4 FY2025
2026-02-11 21:23:21 UTCOpen source
ALBALBEMARLE CORPQ3 FY2026 · ends 2026-09-30
2 metrics2 new
earnings call · 2026-08-07 04:01:23 UTC
2026-08-07 04:01:23 UTClower sequentiallynew
As such, we expect third quarter net sales and EBITDA to be lower sequentially.
ALB · transcript · Q2 FY2026
2026-08-07 04:00:00 UTCOpen source
2026-08-07 04:01:23 UTCdecrease sequentiallynew
Additionally, energy storage margins are expected to decrease sequentially due to the timing of spodumene inventories and also assuming that today's pricing continues for the quarter.
ALB · transcript · Q2 FY2026
2026-08-07 04:00:00 UTCOpen source
ALBALBEMARLE CORPFY2026 · ends 2026-12-31
2 metrics1 new1 maintained
earnings call · 2026-08-07 04:01:23 UTC
2026-08-07 04:01:23 UTC$100Mnew
On a full year basis, we still expect cash flow to be impacted by $87.5 million of deferred revenue related to our 2025 customer prepayment, which benefits EBITDA but does not contribute cash, and approximately $100 million of spend related to idling Kemerton Train 1.
ALB · transcript · Q2 FY2026
2026-08-07 04:00:00 UTCOpen source
2026-08-07 04:01:23 UTC$1.4B – $1.6Bmaintained
As a result, we are increasing our full-year outlook ranges, raising net sales to $1.4 to 1.6 billion and adjusted EBITDA to $275 to 325 million.
ALB · transcript · Q2 FY2026
2026-08-07 04:00:00 UTCOpen source
2026-08-05 20:24:05 UTC$1.4B – $1.6Braised +7.1%
| Specialties net sales | $1.4 - $1.6 billion |
ALB · EX-99.1 · Q2 FY2026
2026-08-05 20:22:29 UTCOpen source
2026-05-08 04:01:18 UTC$1.3B – $1.5Bmaintained
We are raising our guidance for net sales to $1.3 billion-$1.5 billion and for adjusted EBITDA to $225 million-$275 million.
ALB · transcript · Q1 FY2026
2026-05-08 04:00:00 UTCOpen source
2026-05-06 20:21:16 UTC$1.3B – $1.5Braised +7.7%
| Specialties net sales | $1.3 - $1.5 billion |
ALB · EX-99.1 · Q1 FY2026
2026-05-06 20:19:37 UTCOpen source
2026-02-13 05:02:02 UTC$1.2B – $1.4Bmaintained
Looking ahead to 2026, we are introducing full year outlook considerations for the specialties business, including net sales of $1.2-$1.4 billion, adjusted EBITDA of $170-$230 million, and EBITDA margins in the mid-teens.
ALB · transcript · Q4 FY2025
2026-02-13 05:00:00 UTCOpen source
2026-02-11 21:25:10 UTC$1.2B – $1.4Bnew
| Specialties net sales | $1.2 - $1.4 billion |
ALB · EX-99.1 · Q4 FY2025
2026-02-11 21:23:21 UTCOpen source
ALBALBEMARLE CORPQ3 FY2026 · ends 2026-09-30
2 metrics2 new
earnings call · 2026-08-07 04:01:23 UTC
2026-08-07 04:01:23 UTCdecrease sequentiallynew
For the third quarter, net sales and adjusted EBITDA are expected to decrease sequentially due to lower sales volumes and assuming that pricing is lower sequentially for the quarter as it stands today.
ALB · transcript · Q2 FY2026
2026-08-07 04:00:00 UTCOpen source
2026-08-07 04:01:23 UTClower sequentiallynew
As such, we expect third quarter net sales and EBITDA to be lower sequentially.
ALB · transcript · Q2 FY2026
2026-08-07 04:00:00 UTCOpen source
ALBALBEMARLE CORPFY2026 · ends 2026-12-31
1 metric1 new
earnings call · 2026-08-07 04:01:23 UTC
2026-08-07 04:01:23 UTC225K – 235Knew
For the full year, energy storage sales volumes are now expected to be in the range of 225,000-235,000 tons LCE or flat to down 4% year-over-year.
ALB · transcript · Q2 FY2026
2026-08-07 04:00:00 UTCOpen source
ALBALBEMARLE CORPFY2027 · ends 2027-12-31
1 metric1 new
earnings call · 2026-08-07 04:01:23 UTC
2026-08-07 04:01:23 UTC240K – 260Knew
But if you follow our 15% CAGR volume growth that we've said we're doing from 2022 to 2027, that would put 2027 in the range of 240,000-260,000 tons LCE.
ALB · transcript · Q2 FY2026
2026-08-07 04:00:00 UTCOpen source
ALBALBEMARLE CORPFY2026 · ends 2026-12-31
1 metric1 new
earnings call · 2026-08-07 04:01:23 UTC
2026-08-07 04:01:23 UTC900B – 1.1Tnew
We now expect stationary storage battery production of 900-1,100 gigawatt hours in 2026, up 11% or 100 gigawatt hours from our prior forecast.
ALB · transcript · Q2 FY2026
2026-08-07 04:00:00 UTCOpen source
ALBALBEMARLE CORPFY2030+ · ends 2030-12-31
1 metric1 new
earnings call · 2026-08-07 04:01:23 UTC
2026-08-07 04:01:23 UTC1.5T – 2Tnew
We are also raising the low end of our 2030 stationary storage range to between 1,500 and 2,000 gigawatt hours, up approximately 9% from our prior forecast.
ALB · transcript · Q2 FY2026
2026-08-07 04:00:00 UTCOpen source
ALBALBEMARLE CORPFY2026 · ends 2026-12-31
2 metrics1 new1 maintained
earnings call · 2026-08-07 04:01:23 UTC
2026-08-07 04:01:23 UTC30%new
We now expect stationary storage to make up about 30% of 2026 global lithium market demand, nearing parity with light-duty EVs.
ALB · transcript · Q2 FY2026
2026-08-07 04:00:00 UTCOpen source
2026-08-07 04:01:23 UTC$70M – $90Mmaintained
Our outlook ranges continue to reflect the expected impact of supply chain disruptions related to the situation in the Middle East, which we still estimate at approximately $70 to 90 million on an unmitigated basis for the full year.
ALB · transcript · Q2 FY2026
2026-08-07 04:00:00 UTCOpen source
2026-05-08 04:01:18 UTC$70M – $90Mnew
We estimate that the unmitigated full year cost impact of the supply chain disruptions would be approximately $70 million-$90 million and expect it to be offset by the following: reduced interest expense following our debt reduction actions in Q1, and stronger than expected pricing and volumes in the specialties business, which gives us the confidence to increase our full year specialties outlook, which I will cover on slide eight.
ALB · transcript · Q1 FY2026
2026-05-08 04:00:00 UTCOpen source
ALBALBEMARLE CORPFY2030+ · ends 2030-12-31
1 metric1 new
earnings call · 2026-08-07 04:01:23 UTC
2026-08-07 04:01:23 UTC100Knew
As a result of this change, we are also raising the low end of our 2030 forecast for total lithium demand by 100,000 tons.
ALB · transcript · Q2 FY2026
2026-08-07 04:00:00 UTCOpen source
ALBALBEMARLE CORPFY2026 · ends 2026-12-31
2 metrics1 lowered1 maintained
earnings release · 2026-08-05 20:24:05 UTC
2026-08-05 20:24:05 UTC$500Mlowered -13.0%-15.2% vs FY2025
| Capital expenditures | ~$500 million |
ALB · EX-99.1 · Q2 FY2026
2026-08-05 20:22:29 UTCOpen source
2026-05-08 04:01:18 UTC$550M – $600Mmaintained-6.7% – 1.7% vs FY2025
We continue to expect full year CapEx of $550 million-$600 million.
ALB · transcript · Q1 FY2026
2026-05-08 04:00:00 UTCOpen source
2026-05-06 20:21:16 UTC$550M – $600M-6.7% – 1.7% vs FY2025
Albemarle expects its 2026 capital expenditures to be roughly flat compared to 2025, in the range of $550 million to $600 million.
ALB · EX-99.1 · Q1 FY2026
2026-05-06 20:19:37 UTCOpen source
2026-02-13 05:02:02 UTCstable capital spending
We are also targeting additional cost and productivity improvements of $100 million-$150 million and stable capital spending in 2026.
ALB · transcript · Q4 FY2025
2026-02-13 05:00:00 UTCOpen source
2026-02-11 21:25:10 UTC$550M – $600Mnew-6.7% – 1.7% vs FY2025
| Capital expenditures | $550 - $600 million |
ALB · EX-99.1 · Q4 FY2025
2026-02-11 21:23:21 UTCOpen source
2026-08-05 20:24:05 UTC40%maintained
All three scenarios assume flat market pricing flowing through Energy Storage’s current contract book which includes approximately 40% of salts volume (or one-third of total volumes) on long-term agreements.
ALB · EX-99.1 · Q2 FY2026
2026-08-05 20:22:29 UTCOpen source
2026-05-06 20:21:16 UTC40%maintained
All three scenarios assume flat market pricing flowing through Energy Storage’s current contract book which includes approximately 40% of salts volume on long-term agreements.
ALB · EX-99.1 · Q1 FY2026
2026-05-06 20:19:37 UTCOpen source
2026-02-13 05:02:02 UTC40%new
All three scenarios assume flat market pricing across the year, in conjunction with energy storage's current book of business, of which we expect about 40% of lithium salts volume to be sold through our long-term agreements.
ALB · transcript · Q4 FY2025
2026-02-13 05:00:00 UTCOpen source